Loading stock data…
PRVA
$24.24-0.61 (-2.45%)
After Hours$24.24+0.00 (+0.00%)· Last close May 4
Privia Health Group, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Privia Health Group, Inc. in the Healthcare sector is trading at $24.38. The stock is currently 8% below its 52-week high of $26.51, remaining 6.1% above its 200-day moving average. Technical signals show neutral RSI of 65 and bullish MACD crossover, explaining why PRVA maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Overbought levels (RSI 65) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$24.24
Potential Downside
85.9%
Whystock Fair Value$3.41
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus20 analysts
Mean target$31.80+31.2%
Range$25.00 – $40.00
Fundamentals
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.99B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
132.44
Beta
Defensive asset. Lower volatility than the S&P 500.
0.87
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.11%
Volume
Today's trading volume
789,228
Recent News
Hinge Health Stock Sees RS Rating Jump Ahead Of Earnings
Hinge Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
3 Small-Cap Stocks We’re Skeptical Of
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
How The Investment Narrative For Privia Health Group (PRVA) Is Shifting After Mixed Analyst Views
Privia Health Group’s fair value estimate has been nudged from US$31.75 to US$31.80 per share, a very slight price target adjustment that keeps the overall valuation view largely intact. This small move sits within a broader mix of bullish and cautious analyst commentary, with some firms lifting targets into the mid US$30s while others trim into the low US$30s. Read on to see what is driving these differing views and how you can track the evolving narrative around Privia Health from...
Q4 Healthcare Technology for Providers Earnings: Privia Health (NASDAQ:PRVA) Earns Top Marks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers.
2 Profitable Stocks with Promising Prospects and 1 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.